Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrogen Bromide | HCID 260 | — |
| Reactant | Dimethylformamide | HCID 6228 | — |
| Reactant | Nilotinib | HCID 644241 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | Nilotinib hydrobromide | HCID 56592675 | — |
Reaction Steps
Nilotinib base Form A (4.00 g, 7.55 mmol) was suspended in EtOH abs. (40 mL, 10V) at room temperature. The suspension was heated to 80° C. and stirred for 30 min. HBr (48% aq., 1.7 mL, 15.33 mmol, 2.03 eq) was added in one portion. The suspension was stirred for 1 h at 80° C. and then cooled to ambient temperature by removal of the heating source. Stirring was then continued for about 6 h. The resulting yellow solid was isolated by filtration to give Nilotinib HBr form IX. (ARL X-ray powder diffractometer model X'TRA-019).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08937082B2 |
|---|
| Source dataset | uspto-grants-2015_01 |
|---|
| ORD ID | ord-c573a194a17d46e28404de2332a913c6 |
|---|
| Source note | uspto-grants-2015_01 |
|---|